Literature DB >> 7049509

Inhaled aerosols: lung deposition and clinical applications.

S P Newman, J E Agnew, D Pavia, S W Clarke.   

Abstract

Although aerosol deposition in the lungs is often considered in the context of industrial hygiene, aerosols also play an important clinical role. Three principal mechanisms (inertial impaction, gravitational sedimentation and Brownian diffusion) account for the majority of aerosol deposition in the lungs. Deposition depends upon the mode of inhalation, the nature of the particles and physical characteristics of the subject inhaling the particles. Radioaerosols are widely employed in measurements of total and regional deposition, and topographical distribution may also be determined. Aerosols play an important role in the treatment of various forms of respiratory disease, with bronchodilators for the therapy of asthma being particularly important. On average only 10% of the therapeutic aerosol dose actually reaches the lungs. The rate of removal of insoluble radioaerosols deposited in the lungs may be used as an index of mucociliary transport. Aerosols are also used in a variety of other diagnostic and research procedures, particularly for ventilation scanning, alveolar clearance, measurement of alveolar permeability, and for measuring the size of pulmonary air space.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049509     DOI: 10.1088/0143-0815/3/1/001

Source DB:  PubMed          Journal:  Clin Phys Physiol Meas        ISSN: 0143-0815


  9 in total

Review 1.  Sustained release drug delivery to the lungs: an option for the future.

Authors:  J G Hardy; T S Chadwick
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

2.  Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Authors:  Julie D Suman; Beth L Laube; Ta-Chun Lin; Guillaume Brouet; Richard Dalby
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

3.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

4.  Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).

Authors:  Jahidur Rashid; Brijeshkumar Patel; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2017-02-07       Impact factor: 9.776

5.  Quantitative analysis of radioaerosol inhalation and perfusion scintigraphy in dogs.

Authors:  W E van den Brom; C Clercx; A J van Toor; H W de Vries
Journal:  Lung       Date:  1989       Impact factor: 2.584

Review 6.  Aerosol antibiotic treatment in cystic fibrosis.

Authors:  J M Littlewood; S W Smye; H Cunliffe
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

7.  A simple radioaerosol generator and delivery system for pulmonary ventilation studies.

Authors:  M M Ishfaq; S K Ghosh; A B Mostafa; S R Hesslewood; N R Williams; A J Hickey
Journal:  Eur J Nucl Med       Date:  1984

8.  Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.

Authors:  Amy Z Stetten; Steven V Iasella; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  Curr Opin Colloid Interface Sci       Date:  2018-01-13       Impact factor: 6.448

9.  The influence of inhalation technique on Technegas particle deposition and image appearance in normal volunteers.

Authors:  J J Lloyd; J M James; R A Shields; H J Testa
Journal:  Eur J Nucl Med       Date:  1994-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.